pMHC streptamers used for the generation of multivirus-specific T-cell products
| Virus . | Protein . | Peptide . | HLA-restriction . | Specificity included in T-cell product manufacturing for these patients, n . |
|---|---|---|---|---|
| CMV | pp50 | VTEHDTLLY | HLA-A∗01:01 | 3 |
| pp65 | NLVPMVATV | HLA-A∗02:01 | 20 | |
| IE1 | VLEETSVML | HLA-A∗02:01 | 20 | |
| pp65 | QYDPVAALF | HLA-A∗24:02 | 6 | |
| pp65 | TPRVTGGGAM | HLA-B∗07:02 | 7 | |
| IE1 | QIKVRVDMV | HLA-B∗08:01 | 5 | |
| EBV | BMLF1 | GLCTLVAML | HLA-A∗02:01 | 20 |
| EBNA3A | RPPIFIRRL | HLA-B∗07:02 | 7 | |
| BZLF1 | RAKFKQLL | HLA-B∗08:01 | 5 | |
| AdV | HEXON | TDLGQNLLY | HLA-A∗01:01 | 3 |
| E1A | LLDQLIEEV | HLA-A∗02:01 | 20 | |
| HEXON | TYFSLNNKF | HLA-A∗24:02 | 6 | |
| HEXON | KPYSGTAYNAL | HLA-B∗07:02 | 7 |
| Virus . | Protein . | Peptide . | HLA-restriction . | Specificity included in T-cell product manufacturing for these patients, n . |
|---|---|---|---|---|
| CMV | pp50 | VTEHDTLLY | HLA-A∗01:01 | 3 |
| pp65 | NLVPMVATV | HLA-A∗02:01 | 20 | |
| IE1 | VLEETSVML | HLA-A∗02:01 | 20 | |
| pp65 | QYDPVAALF | HLA-A∗24:02 | 6 | |
| pp65 | TPRVTGGGAM | HLA-B∗07:02 | 7 | |
| IE1 | QIKVRVDMV | HLA-B∗08:01 | 5 | |
| EBV | BMLF1 | GLCTLVAML | HLA-A∗02:01 | 20 |
| EBNA3A | RPPIFIRRL | HLA-B∗07:02 | 7 | |
| BZLF1 | RAKFKQLL | HLA-B∗08:01 | 5 | |
| AdV | HEXON | TDLGQNLLY | HLA-A∗01:01 | 3 |
| E1A | LLDQLIEEV | HLA-A∗02:01 | 20 | |
| HEXON | TYFSLNNKF | HLA-A∗24:02 | 6 | |
| HEXON | KPYSGTAYNAL | HLA-B∗07:02 | 7 |